Succinate Mediates Tumorigenic Effects via Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas

Dieter M Matlac, Katerina Hadrava Vanova, Nicole Bechmann, Susan Richter, Julica Folberth, Hans K Ghayee, Guang-Bo Ge, Luma Abunimer, Robert Wesley, Redouane Aherrahrou, Margo Dona, Ángel M Martínez-Montes, Bruna Calsina, Maria J Merino, Markus Schwaninger, Peter M T Deen, Zhengping Zhuang, Jiri Neuzil, Karel Pacak, Hendrik LehnertStephanie M J Fliedner

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number589451
Pages (from-to)589451
JournalFrontiers in Endocrinology
Volume12
DOIs
Publication statusPublished - 12 Mar 2021

Bibliographical note

Copyright © 2021 Matlac, Hadrava Vanova, Bechmann, Richter, Folberth, Ghayee, Ge, Abunimer, Wesley, Aherrahrou, Dona, Martínez-Montes, Calsina, Merino, Schwaninger, Deen, Zhuang, Neuzil, Pacak, Lehnert and Fliedner.

Keywords

  • SDHB gene
  • SUCNR1 (GPR91)
  • paraganglioma
  • succinate
  • succinate receptor 1

Fields of Science and Technology Classification 2012

  • 302 Clinical Medicine

Cite this